Form D · Biotechnology
Turnpoint Medical Devices, Inc.
Lambertville, NJ · CIK 0001616322
Offering snapshot reported Nov 13, 2018 · SEC filing
- Reported sold
- $50K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Nov 2, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2018 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Nov 15, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jul 18, 2017 | Initial | $3,281,096 | No comparison | 46 | SEC filing |
| May 6, 2016 | Amendment | $6,247,092 | $5,472,092vs Aug 11, 2014 | 75 | SEC filing |
| May 6, 2016 | Amendment | $4,491,250 | $3,716,250vs Aug 11, 2014 | 50 | SEC filing |
| Aug 11, 2014 | Initial | $775,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325601
Source: Form D, filed Nov 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Boyajian | Director, Executive |
| Mark Goran | Director |
| Douglas Hulse | Director |
| Joerg H. Klaube | Executive |
| Joerge Klaube | Director, Executive |
| Jeffrey H. Nicholas | Executive |
| Jerry C. Ruddle | Director, Executive |
| John Ruddle | Director, Executive |
| John Toedtman | Director, Executive |
| Richard F. Worthen | Executive |
| Christopher J. York | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Riverwalk Office Complex, Building B 201 S. Main Street
Lambertville, NJ, 08530
Lambertville, NJ, 08530